Form 8-K - Current report:
SEC Accession No. 0001213900-21-040497
Filing Date
2021-08-05
Accepted
2021-08-05 15:23:21
Documents
4
Period of Report
2021-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea145252-8k_abvcbiopharma.htm 8-K 35198
2 UNDERWRITING AGREEMENT, DATED AUGUST 3, 2021, AMONG THE REGISTRANT AND WALLACHBE ea145252ex1-1_abvcbiopharma.htm EX-1.1 177291
3 WARRANT ISSUED TO WALLACHBETH CAPITAL, LLC ea145252ex4-1_abvcbiopharma.htm EX-4.1 101432
4 PRESS RELEASE, DATED AUGUST 3, 2021 ea145252ex99-1_abvcbiopharma.htm EX-99.1 12896
  Complete submission text file 0001213900-21-040497.txt   328251
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 211147764
SIC: 2834 Pharmaceutical Preparations